A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

Panelists discuss how the Inflation Reduction Act (IRA) introduces landmark changes to drug pricing through its negotiation ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...

The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and ...

The Centers for Medicare and Medicaid Services announced lower prices on 15 costly prescription drugs under Medicare, ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

Major solar companies with Chinese connections benefit from Inflation Reduction Act tax credits despite lawmakers' concerns ...

The notice provides an optional interim simplified method of determining whether a corporation is an applicable corporation for purposes of the corporate AMT and relief from the Sec. 6655 penalty for ...